| abstract |
The present invention relates to an extended release matrix formulation capable of being directly compressed to tablets comprising niacin, a release delay agent, and other excipients. The tablets resulting from the invention demonstrate favorable release characteristics and a reduction in the severity, duration and incidents of skin foliation commonly associated with treatment with niacin. |